These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14757324)

  • 41. Association of the C-399T promoter polymorphism of neuropeptide Y with susceptibility to ischemic stroke.
    Kim NS; Oh SM; Ko MM; Cha MH; Kang BK; Bang OS
    Clin Biochem; 2009 Nov; 42(16-17):1699-704. PubMed ID: 19619519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polymorphism in neuropeptide Y influences CSF cholesterol levels but is no major risk factor of Alzheimer's disease.
    Kölsch H; Lütjohann D; Jessen F; Urbach H; von Bergmann K; Maier W; Heun R
    J Neural Transm (Vienna); 2006 Feb; 113(2):231-8. PubMed ID: 15959845
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relevance of neuropeptide Y (NPY) in psychiatry.
    Eaton K; Sallee FR; Sah R
    Curr Top Med Chem; 2007; 7(17):1645-59. PubMed ID: 17979774
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Migraine, but not subarachnoid hemorrhage, is associated with differentially increased NPY-like immunoreactivity in the CSF.
    Valenzuela RF; Donoso MV; Mellado PA; Huidobro-Toro JP
    J Neurol Sci; 2000 Feb; 173(2):140-6. PubMed ID: 10675658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men.
    Nordman S; Ding B; Ostenson CG; Kärvestedt L; Brismar K; Efendic S; Gu HF
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):282-7. PubMed ID: 15926114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropeptide Y immunoreactivity in human cerebrospinal fluid.
    Berrettini WH; Nurnberger JI; DiMaggio DA
    Peptides; 1986; 7(3):455-8. PubMed ID: 3774588
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuropeptide Y gene functional polymorphism influences susceptibility to hypertension in Indian population.
    Bhaskar LV; Thangaraj K; Non AL; Praveen Kumar K; Pardhasaradhi G; Singh L; Rao VR
    J Hum Hypertens; 2010 Sep; 24(9):617-22. PubMed ID: 20033074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Severity of alcohol withdrawal symptoms and the T1128C polymorphism of the neuropeptide Y gene.
    Koehnke MD; Schick S; Lutz U; Willecke M; Koehnke AM; Kolb W; Gaertner I
    J Neural Transm (Vienna); 2002 Nov; 109(11):1423-9. PubMed ID: 12454738
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NPY L7P polymorphism and metabolic diseases.
    Pesonen U
    Regul Pept; 2008 Aug; 149(1-3):51-5. PubMed ID: 18499283
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma neuropeptide Y in patients with major depressive disorder.
    Hashimoto H; Onishi H; Koide S; Kai T; Yamagami S
    Neurosci Lett; 1996 Sep; 216(1):57-60. PubMed ID: 8892391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuropeptide Y polymorphism increases the risk for asthma in overweight subjects; protection from atherosclerosis in asthmatic subjects--the cardiovascular risk in young Finns study.
    Jaakkola U; Kakko T; Juonala M; Lehtimäki T; Viikari J; Jääskeläinen AE; Mononen N; Kähönen M; Koskinen T; Keltikangas-Järvinen L; Raitakari O; Kallio J
    Neuropeptides; 2012 Dec; 46(6):321-8. PubMed ID: 23122776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of cerebrospinal fluid (CSF) and plasma NPY levels in normal volunteers over a 24-h timeframe.
    Baker DG; Bertram TM; Patel PM; Barkauskas DA; Clopton P; Patel S; Geracioti TD; Haji U; O'Connor DT; Nievergelt CM; Hauger RL
    Psychoneuroendocrinology; 2013 Oct; 38(10):2378-82. PubMed ID: 23759334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Somatostatin and neuropeptide Y in cerebrospinal fluid: correlations with severity of disease and clinical signs in Alzheimer's disease and frontotemporal dementia.
    Minthon L; Edvinsson L; Gustafson L
    Dement Geriatr Cogn Disord; 1997; 8(4):232-9. PubMed ID: 9213068
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leucine 7 to proline 7 polymorphism in the neuropeptide y gene is associated with retinopathy in type 2 diabetes.
    Niskanen L; Voutilainen-Kaunisto R; Teräsvirta M; Karvonen MK; Valve R; Pesonen U; Laakso M; Uusitupa MI; Koulu M
    Exp Clin Endocrinol Diabetes; 2000; 108(3):235-6. PubMed ID: 10926322
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Processing of neuropeptide Y and somatostatin in human cerebrospinal fluid as monitored by radioimmunoassay and mass spectrometry.
    Nilsson C; Westman A; Blennow K; Ekman R
    Peptides; 1998; 19(7):1137-46. PubMed ID: 9786162
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nutrient intake, weight, and Leu7Pro polymorphism in prepro-neuropeptide Y in children.
    Karvonen MK; Ruottinen S; Koulu M; Pesonen U; Niinikoski H; Rask-Nissilä L; Simell O; Rönnemaa T
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4664-8. PubMed ID: 16912140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of hypothalamic neuropeptide Y gene expression by insulin.
    Schwartz MW; Sipols AJ; Marks JL; Sanacora G; White JD; Scheurink A; Kahn SE; Baskin DG; Woods SC; Figlewicz DP
    Endocrinology; 1992 Jun; 130(6):3608-16. PubMed ID: 1597158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men.
    Karvonen MK; Valkonen VP; Lakka TA; Salonen R; Koulu M; Pesonen U; Tuomainen TP; Kauhanen J; Nyyssönen K; Lakka HM; Uusitupa MI; Salonen JT
    Atherosclerosis; 2001 Nov; 159(1):145-51. PubMed ID: 11689216
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of Neuropeptide-Y (NPY) and Interleukin-1beta (IL1B), Genotype-Phenotype Correlation and Plasma Lipids with Type-II Diabetes.
    Patel R; Dwivedi M; Mansuri MS; Ansarullah ; Laddha NC; Thakker A; Ramachandran AV; Begum R
    PLoS One; 2016; 11(10):e0164437. PubMed ID: 27749914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuropeptide Y polymorphism and alcohol consumption in middle-aged men.
    Kauhanen J; Karvonen MK; Pesonen U; Koulu M; Tuomainen TP; Uusitupa MI; Salonen JT
    Am J Med Genet; 2000 Jul; 93(2):117-21. PubMed ID: 10869113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.